KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Synopsys (SNPS) Research & Development: 2009-2025

Historic Research & Development for Synopsys (SNPS) over the last 16 years, with Jul 2025 value amounting to $625.3 million.

  • Synopsys' Research & Development rose 22.88% to $625.3 million in Q3 2025 from the same period last year, while for Jul 2025 it was $2.3 billion, marking a year-over-year increase of 14.75%. This contributed to the annual value of $2.1 billion for FY2024, which is 12.56% up from last year.
  • According to the latest figures from Q3 2025, Synopsys' Research & Development is $625.3 million, which was up 12.87% from $554.0 million recorded in Q2 2025.
  • In the past 5 years, Synopsys' Research & Development registered a high of $625.3 million during Q3 2025, and its lowest value of $357.5 million during Q1 2021.
  • Its 3-year average for Research & Development is $517.4 million, with a median of $508.9 million in 2024.
  • Per our database at Business Quant, Synopsys' Research & Development dropped by 10.34% in 2022 and then rose by 25.53% in 2023.
  • Synopsys' Research & Development (Quarterly) stood at $413.9 million in 2021, then declined by 10.34% to $371.1 million in 2022, then climbed by 25.53% to $465.8 million in 2023, then grew by 19.11% to $554.8 million in 2024, then rose by 22.88% to $625.3 million in 2025.
  • Its Research & Development stands at $625.3 million for Q3 2025, versus $554.0 million for Q2 2025 and $553.2 million for Q1 2025.